The University of Edinburgh
The clinical significance of loss of DNA mismatch repair in ovarian cancer patients: an immunohistochemical study
Abstract
dc:description.abstractLoss of mismatch repair (MMR) and, in particular, loss of MLH1 is associated with acquired cisplatin resistance of ovarian tumour cell line models. The aim of this thesis is to examine in ovarian cancer patients the clinical prognostic significance of the MMR proteins MLH1 and MSH2 when measured at disease presentation. We have developed immunohistochemistry (IHC) and a scoring system for the expression of MLH1 and MSH2 in paraffin embedded tissues. We have scored both the intensity of staining (I-score) and percentage of cells staining (%-score). We have validated this technique with good agreement in scoring over time, between blocks and between observers (inter-observer kappa scores of ≥ 0.629, intra-observer kappa scores of > 0.646 and intra-slide kappa scores of ≥ 0.583). There was a positive correlation of Ki67, (a proliferation marker), with I-MLH1, %-MLHl and %-MSH2 scores (p=0.002; <0.001 and 0.001) but not with p53 scores.
Degree
thesis:*- Grantor dc:publisher
- The University of Edinburgh
- Year dc:date.issued
- 2002
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Mackean, Melanie
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- http://hdl.handle.net/1842/29239